Recent advances in potential clinical application of ghrelin in obesity

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Delporte, Christine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ANTIOBESITY AGENT; BIM 28163; CYT 009 GHR; EX 1350; GHRELIN; GHRELIN O ACYLTRANSFERASE; GSK 1614343; HAPTEN; JMV 2844; JMV 2866; NOX B11 2; NOX B11 3; PENTAPEPTIDE; PIPERIDINE DERIVATIVE; QUINAZOLINONE DERIVATIVE; TZP 301; UNCLASSIFIED DRUG; VACCINE; YIL 781;

BITTER TASTE; FOOD INTAKE; HUMAN; NONHUMAN; OBESITY; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW;

EID: 84866253294     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/535624     Document Type: Review

References (91)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 6762 656 660 2-s2.0-0033540056 10.1038/45230 (Pubitemid 129516334)
2. Gutierrez J. A., Solenberg P. J., Perkins D. R., Willency J. A., Knierman M. D., Jin Z., Witcher D. R., Luo S., Onyia J. E., Hale J. E., Ghrelin octanoylation mediated by an orphan lipid transferase. Proceedings of the National Academy of Sciences of the United States of America 2008 105 17 6320 6325 2-s2.0-44049094269 10.1073/pnas.0800708105 (Pubitemid 351758344)
3. Yang J., Brown M. S., Liang G., Grishin N. V., Goldstein J. L., Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008 132 3 387 396 2-s2.0-38849090670 10.1016/j.cell.2008.01.017 (Pubitemid 351192001)
4. Cummings D. E., Purnell J. Q., Frayo R. S., Schmidova K., Wisse B. E., Weigle D. S., A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001 50 8 1714 1719 2-s2.0-0035433977 (Pubitemid 33641587)
5. Tschöp M., Wawarta R., Riepl R. L., Friedrich S., Bidlingmaier M., Landgraf R., Folwaczny C., Post-prandial decrease of circulating human ghrelin levels. Journal of Endocrinological Investigation 2001 24 6 RC19 RC21 (Pubitemid 32573786)
6. Wren A. M., Seal L. J., Cohen M. A., Brynes A. E., Frost G. S., Murphy K. G., Dhillo W. S., Ghatei M. A., Bloom S. R., Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 12 5992 5995 2-s2.0-0035216623 10.1210/jc.86.12.5992 (Pubitemid 33152655)
7. Trudel L., Tomasetto C., Rio M. C., Bouin M., Plourde V., Eberling P., Poitras P., Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. American Journal of Physiology 2002 282 6 G948 G952 2-s2.0-0036083505 (Pubitemid 34651600)
8. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M. S., Suganuma T., Matsukura S., Kangawa K., Nakazato M., Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000 141 11 4255 4261 2-s2.0-0033679897
9. Rindi G., Necchi V., Savio A., Torsello A., Zoli M., Locatelli V., Raimondo F., Cocchi D., Solcia E., Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochemistry and Cell Biology 2002 117 6 511 519 2-s2.0-0036085711 10.1007/s00418-002-0415-1 (Pubitemid 34666954)
10. Sakata I., Nakamura K., Yamazaki M., Matsubara M., Hayashi Y., Kangawa K., Sakai T., Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract. Peptides 2002 23 3 531 536 2-s2.0-0036171253 10.1016/S0196-9781(01)00633-7 (Pubitemid 34143270)
11. Hosoda H., Kojima M., Mizushima T., Shimizu S., Kangawa K., Structural divergence of human ghrelin: identification of multiple ghrelin-derived molecules produced by post-translational processing. Journal of Biological Chemistry 2003 278 1 64 70 2-s2.0-0346949031 10.1074/jbc.M205366200 (Pubitemid 36043544)
12. Nishi Y., Hiejima H., Hosoda H., Kaiya H., Mori K., Fukue Y., Yanase T., Nawata H., Kangawa K., Kojima M., Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 2005 146 5 2255 2264 2-s2.0-20244366719 10.1210/en.2004-0695 (Pubitemid 40577513)
13. Patterson M., Murphy K. G., Le Roux C. W., Ghatei M. A., Bloom S. R., Characterization of ghrelin-like immunoreactivity in human plasma. Journal of Clinical Endocrinology and Metabolism 2005 90 4 2205 2211 2-s2.0-17844402979 10.1210/jc.2004-1641 (Pubitemid 40586263)
14. Shanado Y., Kometani M., Uchiyama H., Koizumi S., Teno N., Lysophospholipase I identified as a ghrelin deacylation enzyme in rat stomach. Biochemical and Biophysical Research Communications 2004 325 4 1487 1494 2-s2.0-8844239339 10.1016/j.bbrc.2004.10.193 (Pubitemid 39535930)
15. Satou M., Nishi Y., Yoh J., Hattori Y., Sugimoto H., Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 2010 151 10 4765 4775 2-s2.0-77957266562 10.1210/en.2010-0412
16. De Vriese C., Gregoire F., Lema-Kisoka R., Waelbroeck M., Robberecht P., Delporte C., Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 2004 145 11 4997 5005 2-s2.0-9244225118 10.1210/en.2004-0569 (Pubitemid 39551118)
17. Akamizu T., Shinomiya T., Irako T., Fukunaga M., Nakai Y., Nakai Y., Kangawa K., Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. Journal of Clinical Endocrinology and Metabolism 2005 90 1 6 9 2-s2.0-12244299859 10.1210/jc.2004-1640 (Pubitemid 40116625)
18. Hosoda H., Doi K., Nagaya N., Okumura H., Nakagawa E., Enomoto M., Ono F., Kangawa K., Optimum collection and storage conditions for ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl ghrelin in blood samples. Clinical Chemistry 2004 50 6 1077 1080 2-s2.0-2642570058 10.1373/clinchem.2003.025841 (Pubitemid 38725803)
19. De Vriese C., Hacquebard M., Gregoire F., Carpentier Y., Delporte C., Ghrelin interacts with human plasma lipoproteins. Endocrinology 2007 148 5 2355 2362 2-s2.0-34249788733 10.1210/en.2006-1281 (Pubitemid 46997038)
20. Li B., Duysen E. G., Lockridge O., The butyrylcholinesterase knockout mouse is obese on a high-fat diet. Chemico-Biological Interactions 2008 175 13 88 91 2-s2.0-50649114884 10.1016/j.cbi.2008.03.009
21. Beaumont N. J., Skinner V. O., Tan T. M. M., Ramesh B. S., Byrne D. J., MacColl G. S., Keen J. N., Bouloux P. M., Mikhailidis D. P., Bruckdorfer K. R., Vanderpump M. P., Srai K. S., Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. Journal of Biological Chemistry 2003 278 11 8877 8880 2-s2.0-0037762542 10.1074/jbc.C200575200 (Pubitemid 36800362)
22. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I., Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes 2001 50 7-12 2438 2443 2-s2.0-0035513696 (Pubitemid 33642759)
23. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., Matsukura S., A role for ghrelin in the central regulation of feeding. Nature 2001 409 6817 194 198 2-s2.0-0035843183 10.1038/35051587 (Pubitemid 32144284)
24. Shintani M., Ogawa Y., Ebihara K., Aizawa-Abe M., Miyanaga F., Takaya K., Hayashi T., Inoue G., Hosoda K., Kojima M., Kangawa K., Nakao K., Rapid publication ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001 50 2 227 232 2-s2.0-0035143816 (Pubitemid 32127276)
25. Tschop M., Smiley D. L., Heiman M. L., Ghrelin induces adiposity in rodents. Nature 2000 407 6806 908 913 2-s2.0-0034687376 10.1038/35038090
26. Soriano-Guillén L., Barrios V., Campos-Barros A., Argente J., Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. Journal of Pediatrics 2004 144 1 36 42 2-s2.0-0346494433 10.1016/j.jpeds.2003.10.036 (Pubitemid 38091419)
27. Castaeda T. R., Tong J., Datta R., Culler M., Tschöp M. H., tschoemh@ucmail.uc.edu Ghrelin in the regulation of body weight and metabolism. Frontiers in Neuroendocrinology 2010 31 1 44 60 10.1016/j.yfrne.2009.10.008
28. Williams D. L., Grill H. J., Cummings D. E., Kaplan J. M., Overfeeding-induced weight gain suppresses plasma ghrelin levels in rats. Journal of Endocrinological Investigation 2006 29 10 863 868 2-s2.0-33846495033 (Pubitemid 46165009)
29. Palik E., Baranyi E., Melczer Z., Audikovszky M., Szöcs A., Winkler G., Cseh K., Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Research and Clinical Practice 2007 76 3 351 357 2-s2.0-33947590069 10.1016/j.diabres.2006.09.005 (Pubitemid 46482713)
30. Hosojima H., Togo T., Odawara T., Hasegawa K., Miura S., Kato Y., Kanai A., Kase A., Uchikado H., Hirayasu Y., Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. Journal of Psychopharmacology 2006 20 1 75 79 2-s2.0-33645214469 10.1177/0269881105056647
31. Otukonyong E. E., Dube M. G., Torto R., Kalra P. S., Kalra S. P., High-fat Diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obesity Research 2005 13 6 991 999 2-s2.0-25144497560
32. Perez-Tilve D., pereztdo@ucmail.uc.edu Heppner K., Kirchner H., Lockie S. H., Woods S. C., Smiley D. L., Tschöp M., Pfluger P., Ghrelin-induced adiposity is independent of orexigenic effects. The FASEB Journal 2011 25 8 2814 2822 10.1096/fj.11-183632
33. Sun Y., Wang P., Zheng H., Smith R. G., Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proceedings of the National Academy of Sciences of the United States of America 2004 101 13 4679 4684 2-s2.0-1842480284 10.1073/pnas.0305930101 (Pubitemid 38437470)
34. Zigman J. M., Nakano Y., Coppari R., Balthasar N., Marcus J. N., Lee C. E., Jones J. E., Deysher A. E., Waxman A. R., White R. D., Williams T. D., Lachey J. L., Seeley R. J., Lowell B. B., Elmquist J. K., Mice lacking ghrelin receptors resist the development of diet-induced obesity. Journal of Clinical Investigation 2005 115 12 3564 3572 2-s2.0-31044451759 10.1172/JCI26002 (Pubitemid 43121844)
35. Halem H. A., Taylor J. E., Dong J. Z., Shen Y., Datta R., Abizaid A., Diano S., Horvath T. L., Culler M. D., A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain. Neuroendocrinology 2005 81 5 339 349 2-s2.0-27344437877 10.1159/000088796 (Pubitemid 41527865)
36. Inhoff T., Wiedenmann B., Klapp B. F., Mönnikes H., Kobelt P., Is desacyl ghrelin a modulator of food intake? Peptides 2009 30 5 991 994 2-s2.0-67349169801 10.1016/j.peptides.2009.01.019
37. Stengel A., Goebel M., Wang L., Taché Y., Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides 2010 31 2 357 369 2-s2.0-74149087844 10.1016/j.peptides.2009.11.019
38. Kirchner H., Gutierrez J. A., Solenberg P. J., Pfluger P. T., Czyzyk T. A., Willency J. A., Schürmann A., Joost H. G., Jandacek R. J., Hale J. E., Heiman M. L., Tschöp M. H., GOAT links dietary lipids with the endocrine control of energy balance. Nature Medicine 2009 15 7 741 745 2-s2.0-67650423944 10.1038/nm.1997
39. Cummings D. E., Clement K., Purnell J. Q., Vaisse C., Foster K. E., Frayo R. S., Schwartz M. W., Basdevant A., Weigle D. S., Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine 2002 8 7 643 644 2-s2.0-0036061558 10.1038/nm0702-643 (Pubitemid 34778697)
40. Delparigi A., adelpari@mail.nih.gov Tschöp M., Heiman M. L., Salbe A. D., Vozarova B., Sell S. M., Bunt J. C., Tataranni P. A., High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 12 5461 5464 10.1210/jc.2002-020871 (Pubitemid 36034344)
41. Kissebah A. H., Sonnenberg G. E., Myklebust J., Goldstein M., Broman K., James R. G., Marks J. A., Krakower G. R., Jacob H. J., Weber J., Martin L., Blangero J., Comuzzie A. G., Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14478 14483 2-s2.0-14344273991 10.1073/pnas.97.26.14478 (Pubitemid 32016601)
42. Yeh A. H., Jeffery P. L., Duncan R. P., Herington A. C., Chopin L. K., Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clinical Cancer Research 2005 11 23 8295 8303 2-s2.0-28544441759 10.1158/1078-0432.CCR-05-0443 (Pubitemid 41746940)
43. Bing C., Ambye L., Fenger M., Jorgensen T., Borch-Johnsen K., Madsbad S., Urhammer S. A., Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabetic Medicine 2005 22 9 1157 1160 2-s2.0-24044462104 10.1111/j.1464-5491. 2005.01575.x (Pubitemid 41224173)
44. Hinney A., Hoch A., Geller F., Schäfer H., Siegfried W., Goldschmidt H., Remschmidt H., Hebebrand J., Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. Journal of Clinical Endocrinology and Metabolism 2002 87 6 2716 2719 10.1210/jc.87.6.2716 (Pubitemid 34655335)
45. Larsen L. H., Gjesing A. P., Sorensen T. I. A., Hamid Y. H., Echwald S. M., Toubro S., Black E., Astrup A., Hansen T., Pedersen O., Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes. Clinical Biochemistry 2005 38 5 420 424 2-s2.0-20144389880 10.1016/j. clinbiochem.2005.01.008
46. Ukkola O., Ravussin E., Jacobson P., Snyder E. E., Chagnon M., Sjostrom L., Bouchard C., Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3996 3999 2-s2.0-0034880513 10.1210/jc.86.8.3996 (Pubitemid 32756010)
47. Vivenza D., Rapa A., Castellino N., Bellone S., Petri A., Vacca G., Aimaretti G., Broglio F., Bona G., Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents. European Journal of Endocrinology 2004 151 1 127 133 2-s2.0-4344690017 10.1530/eje.0.1510127 (Pubitemid 39117375)
48. Wang H. J., Geller F., Dempfle A., Schäuble N., Friedel S., Lichtner P., Fontenla-Horro F., Wudy S., Hagemann S., Gortner L., Huse K., Remschmidt H., Bettecken T., Meitinger T., Schäfer H., Hebebrand J., Hinney A., Anke.Hinney@med.uni-marburg.de Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. Journal of Clinical Endocrinology and Metabolism 2004 89 1 157 162 10.1210/jc.2003-031395 (Pubitemid 38183875)
49. Korbonits M., Gueorguiev M., O'Grady E., Lecoeur C., Swan D. C., Mein C. A., Weill J., Grossman A. B., Froguel P., A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. Journal of Clinical Endocrinology and Metabolism 2002 87 8 4005 4008 2-s2.0-0036342530 10.1210/jc.87.8.4005 (Pubitemid 34879563)
50. Martin G. R., Loredo J. C., Sun G., Lack of association of ghrelin precursor gene variants and percentage body fat or serum lipid profiles. Obesity 2008 16 4 908 912 2-s2.0-41549128569 10.1038/oby.2007.125 (Pubitemid 351465654)
51. Miraglia D. G., emanuele.miraglia@unina2.it Santoro N., Cirillo G., Raimondo P., Grandone A., D'Aniello A., Di Nardo M., Perrone L., Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity. International Journal of Obesity 2004 28 3 447 450 10.1038/sj.ijo.0802572 (Pubitemid 38296960)
52. Dardennes R. M., Zizzari P., Tolle V., Foulon C., Kipman A., Romo L., Iancu-Gontard D., Boni C., Sinet P. M., Thérèse Bluet M., Estour B., Mouren M. C., Guelfi J. D., Rouillon F., Gorwood P., Epelbaum J., Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology 2007 32 2 106 113 2-s2.0-33847207165 10.1016/j.psyneuen.2006.11.003
53. Tschöp M., Weyer C., Tataranni P. A., Devanarayan V., Ravussin E., Heiman M. L., Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 4 707 709 2-s2.0-0035082265 (Pubitemid 32242624)
54. Ikezaki A., Hosoda H., Ito K., Iwama S., Miura N., Matsuoka H., Kondo C., Kojima M., Kangawa K., Sugihara S., Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002 51 12 3408 3411 2-s2.0-0036896934 (Pubitemid 35403443)
55. Pöykkö S. M., seppo.poykko@ppshp.fi Kellokoski E., Hörkkö S., Kauma H., Kesäniemi Y. A., Ukkola O., Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003 52 10 2546 2553 10.2337/diabetes.52.10.2546 (Pubitemid 37210544)
56. Pacifico L., Poggiogalle E., Costantino F., Anania C., Ferraro F., Chiarelli F., Chiesa C., Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. European Journal of Endocrinology 2009 161 6 861 870 2-s2.0-72949115929 10.1530/EJE-09-0375
57. Delhanty P. J., p.delhanty@erasmusmc.nl van der Lely A. J., Ghrelin and glucose homeostasis. Peptides 2011 32 11 2309 2318 10.1016/j.peptides.2011.03. 001
58. Sangiao-Alvarellos S., Cordido F., Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications. International Journal of Peptides 2010 2010 25 234709 10.1155/2010/234709
59. Sakata I., Yang J., Lee C. E., Osborne-Lawrence S., Rovinsky S. A., Elmquist J. K., Zigman J. M., Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. American Journal of Physiology 2009 297 1 E134 E141 2-s2.0-67649207827 10.1152/ajpendo.90859.2008
60. Ohgusu H., Shirouzu K., Nakamura Y., Nakashima Y., Ida T., Sato T., Kojima M., Ghrelin O-acyltransferase (GOAT) has a preference for n-hexanoyl-CoA over n-octanoyl-CoA as an acyl donor. Biochemical and Biophysical Research Communications 2009 386 1 153 158 2-s2.0-67649210216 10.1016/j.bbrc.2009.06.001
61. Kojima M., Kangawa K., Structure and function of Ghrelin. Results and Problems in Cell Differentiation 2008 46 89 115 2-s2.0-43849098185 10.1007/4002007049
62. Cummings D. E., Ghrelin and the short- and long-term regulation of appetite and body weight. Physiology and Behavior 2006 89 1 71 84 2-s2.0-33746739498 10.1016/j.physbeh.2006.05.022 (Pubitemid 44164467)
63. Liu J., Prudom C. E., Nass R., Pezzoli S. S., Oliveri M. C., Johnson M. L., Veldhuis P., Gordon D. A., Howard A. D., Witcher D. R., Geysen H. M., Gaylinn B. D., Thorner M. O., Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. Journal of Clinical Endocrinology and Metabolism 2008 93 5 1980 1987 2-s2.0-43249089526 10.1210/jc.2007-2235 (Pubitemid 351656547)
64. González C. R., Vázquez M. J., López M., Diéguez C., carlos.dieguez@usc.es Influence of chronic undernutrition and leptin on GOAT mRNA levels in rat stomach mucosa. Journal of Molecular Endocrinology 2008 41 5-6 415 421 10.1677/JME-08-0102
65. Zhao T. J., Liang G., Li R. L., Xie X., Sleeman M. W., Murphy A. J., Valenzuela D. M., Yancopoulos G. D., Goldstein J. L., Brown M. S., Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proceedings of the National Academy of Sciences of the United States of America 2010 107 16 7467 7472 2-s2.0-77952165770 10.1073/pnas.1002271107
66. Müller T. D., Tschöp M. H., tschoemh@ucmail.uc.edu Jarick I., Ehrlich S., Scherag S., Herpertz-Dahlmann B., Zipfel S., Herzog W., de Zwaan M., Burghardt R., Fleischhaker C., Klampfl K., Wewetzer C., Herpertz S., Zeeck A., Tagay S., Burgmer M., Pfluger P. T., Scherag A., Hebebrand J., Hinney A., Genetic variation of the ghrelin activator gene ghrelin O-acyltransferase (GOAT) is associated with anorexia nervosa. Journal of Psychiatric Research 2011 45 5 706 711 10.1016/j.jpsychires.2010.10.001
67. Barnett B. P., Hwang Y., Taylor M. S., Kirchner H., Pfluger P. T., Bernard V., Lin Y. Y., Bowers E. M., Mukherjee C., Song W. J., Longo P. A., Leahy D. J., Hussain M. A., Tschöp M. H., Boeke J. D., Cole P. A., Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010 330 6011 1689 1692 2-s2.0-78650304822 10.1126/science.1196154
68. Zorrilla E. P., Iwasaki S., Moss J. A., Chang J., Otsuji J., Inoue K., Meijler M. M., Janda K. D., Vaccination against weight gain. Proceedings of the National Academy of Sciences of the United States of America 2006 103 35 13226 13231 2-s2.0-33748354456 10.1073/pnas.0605376103 (Pubitemid 44338944)
69. Lu S. C., Xu J., Chinookoswong N., Liu S., Steavenson S., Gegg C., Brankow D., Lindberg R., Veniant M., Gu W., An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. Molecular Pharmacology 2009 75 4 901 907 2-s2.0-63849244534 10.1124/mol.108.052852
70. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M. A., Kasuga M., Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003 52 7 947 952 2-s2.0-0038304457 10.1136/gut.52.7.947 (Pubitemid 36765284)
71. Shearman L. P., Wang S. P., Helmling S., Stribling D. S., Mazur P., Ge L., Wang L., Klussmann S., Macintyre D. E., Howard A. D., Strack A. M., Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice. Endocrinology 2006 147 3 1517 1526 2-s2.0-32644448802 10.1210/en.2005-0993 (Pubitemid 43244387)
72. Kobelt P., Helmling S., Stengel A., Wlotzka B., Andresen V., Klapp B. F., Wiedenmann B., Klussmann S., Mönnikes H., Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats. Gut 2006 55 6 788 792 2-s2.0-33646800511 10.1136/gut.2004.061010 (Pubitemid 43764547)
73. Helmling S., Maasch C., Eulberg D., Buchner K., Schröder W., Lange C., Vonhoff S., Wlotzka B., Tschöp M. H., Rosewicz S., Klussmann S., Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer. Proceedings of the National Academy of Sciences of the United States of America 2004 101 36 13174 13179 2-s2.0-4444260060 10.1073/pnas.0404175101 (Pubitemid 39209638)
74. Becskei C., Bilik K. U., Klussmann S., Jarosch F., Lutz T. A., Riediger T., The anti-ghrelin spiegelmer NOX-B11-3 blocks ghrelin- but not fasting-induced neuronal activation in the hypothalamic arcuate nucleus. Journal of Neuroendocrinology 2008 20 1 85 92 2-s2.0-36949026161 10.1111/j.1365-2826. 2007.01619.x (Pubitemid 350239152)
75. Beck B., Richy S., Stricker-Krongrad A., Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats. Life Sciences 2004 76 4 473 478 2-s2.0-7644219561 10.1016/j.lfs.2004.09.001 (Pubitemid 39458314)
76. Rudolph J., Esler W. P., O'Connor S., Coish P. D. G., Wickens P. L., Brands M., Bierer D. E., Bloomquist B. T., Bondar G., Chen L., Chuang C. Y., Claus T. H., Fathi Z., Fu W., Khire U. R., Kristie J. A., Liu X. G., Lowe D. B., McClure A. C., Michels M., Ortiz A. A., Ramsden P. D., Schoenleber R. W., Shelekhin T. E., Vakalopoulos A., Tang W., Wang L., Yi L., Gardell S. J., Livingston J. N., Sweet L. J., Bullock W. H., Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. Journal of Medicinal Chemistry 2007 50 21 5202 5216 2-s2.0-35348825010 10.1021/jm070071+ (Pubitemid 47585718)
77. Esler W. P., Rudolph J., Claus T. H., Tang W., Barucci N., Brown S. E., Bullock W., Daly M., DeCarr L., Li Y., Milardo L., Molstad D., Zhu J., Gardell S. J., Livingston J. N., Sweet L. J., Small-molecule Ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 2007 148 11 5175 5185 2-s2.0-35548949948 10.1210/en.2007-0239 (Pubitemid 350012622)
78. Demange L., Boeglin D., Moulin A., Mousseaux D., Ryan J., Bergé G., Gagne D., Heitz A., Perrissoud D., Locatelli V., Torsello A., Galleyrand J. C., Fehrentz J. A., Martinez J., Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1. Journal of Medicinal Chemistry 2007 50 8 1939 1957 2-s2.0-34247239893 10.1021/jm070024h (Pubitemid 46626603)
79. Moulin A., Demange L., Ryan J., M'Kadmi C., Galleyrand J. C., Martinez J., Fehrentz J. A., Trisubstituted 1,2,4-triazoles as ligands for the ghrelin receptor: on the significance of the orientation and substitution at position 3. Bioorganic and Medicinal Chemistry Letters 2008 18 1 164 168 2-s2.0-37649022059 10.1016/j.bmcl.2007.10.113
80. Leyris J. P., Roux T., Trinquet E., Verdié P., Fehrentz J. A., Oueslati N., Douzon S., Bourrier E., Lamarque L., Gagne D., Galleyrand J. C., M'kadmi C., Martinez J., Mary S., Banères J. L., Marie J., jacky.marie@univ-montp1.fr Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a. Analytical Biochemistry 2011 408 2 253 262 10.1016/j.ab.2010.09.030
81. Yu M., Lizarzaburu M., Beckmann H., Connors R., Dai K., Haller K., Li C., Liang L., Lindstrom M., Ma J., Motani A., Wanska M., Zhang A., Li L., Medina J. C., Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity. Bioorganic and Medicinal Chemistry Letters 2010 20 5 1758 1762 2-s2.0-76649095334 10.1016/j.bmcl.2010.01.043
82. Sabbatini F. M., Di Fabio R., Corsi M., Cavanni P., Bromidge S. M., St-Denis Y., D'Adamo L., Contini S., Rinaldi M., Guery S., Savoia C., Mundi C., Perini B., Carpenter A. J., Forno G. D., Faggioni F., Tessari M., Pavone F., Francesco C. D., Buson A., Mattioli M., Perdona' E., Melotto S., DemangeL R. J., Mousseaux D., Sanchez P., Berge G., Gagne D., Perrissoud D., Locatelli V., Torsello A., Galleyrand J. C., Fehrentz J. A., Martinez J., Discovery process and characterization of novel carbohydrazide derivatives as potent and selective GHSR1a antagonists. ChemMedChem 2010 5 9 1450 1455 2-s2.0-77956402546 10.1002/cmdc.201000185
83. Perdonà E., Faggioni F., Buson A., Sabbatini F. M., Corti C., Corsi M., Pharmacological characterization of the ghrelin receptor antagonist, GSK1614343 in rat RC-4B/C cells natively expressing GHS type 1a receptors. European Journal of Pharmacology 2011 650 1 178 183 2-s2.0-78649738318 10.1016/j.ejphar.2010.10.042
84. Costantini V. J., vivian.costantini@aptuit.com Vicentini E., Sabbatini F. M., Valerio E., Lepore S., Tessari M., Sartori M., Michielin F., Melotto S., Merlo Pich E., Corsi M., GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs. Neuroendocrinology 2011 94 2 158 168 10.1159/000328968
85. Halem H. A., Taylor J. E., Dong J. Z., Shen Y., Datta R., Abizaid A., Diano S., Horvath T., Zizzari P., Bluet-Pajot M. T., Epelbaum J., Culler M. D., Novel analogs of ghrelin: physiological and clinical implications. European Journal of Endocrinology 2004 151 1 S71 S75 2-s2.0-4644308857 10.1530/eje.0.151S071 (Pubitemid 39276351)
86. Depoortere I., Targeting the ghrelin receptor to regulate food intake. Regulatory Peptides 2009 156 13 13 23 2-s2.0-67649124250 10.1016/j.regpep.2009. 04.002
87. Holst B., Cygankiewicz A., Jensen T. H., Ankersen M., Schwartz T. W., High constitutive signaling of the ghrelin receptoridentification of a potent inverse agonist. Molecular Endocrinology 2003 17 11 2201 2210 2-s2.0-0242330291 10.1210/me.2003-0069 (Pubitemid 37352532)
88. Holliday N. D., Holst B., Rodionova E. A., Schwartz T. W., Cox H. M., Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Molecular Endocrinology 2007 21 12 3100 3112 2-s2.0-36849039489 10.1210/me.2007-0254 (Pubitemid 350223518)
89. Holst B., Schwartz T. W., Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends in Pharmacological Sciences 2004 25 3 113 117 2-s2.0-1342264249 10.1016/j.tips.2004.01.010 (Pubitemid 38264498)
90. Holst B., Lang M., Brandt E., Bach A., Howard A., Frimurer T. M., Beck-Sickinger A., Schwartz T. W., Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor. Molecular Pharmacology 2006 70 3 936 946 2-s2.0-33747603675 10.1124/mol.106.024422 (Pubitemid 44268450)
91. Janssen S., Laermans J., Verhulst P. J., Thijs T., Tack J., Depoortere I., Bitter taste receptors and α -gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proceedings of the National Academy of Sciences of the United States of America 2011 108 5 2094 2099 2-s2.0-79952138344 10.1073/pnas.1011508108